Support H-Net | Buy Books Here | Help Support the NBN and NBN en Español on Patreon | Visit New Books Network en Español!
- African Studies
- African American Studies
- American Politics
- American Studies
- American South
- American West
- Asian American Studies
- Australian and New Zealand Studies
- British Studies
- Canadian Studies
- Caribbean Studies
- Central Asian Studies
- Chinese Studies
- East Asian Studies
- Eastern European Studies
- European Politics
- French Studies
- German Studies
- Iberian Studies
- India Studies
- Indian Ocean World
- Iranian Studies
- Irish Studies
- Israel Studies
- Italian Studies
- Japanese Studies
- Korean Studies
- Latino Studies
- Latin American Studies
- Mexican Studies
- Middle Eastern Studies
- Native American Studies
- Pacific Studies
- Polish Studies
- Russian and Eurasian Studies
- Southeast Asian Studies
- South Asian Studies
- Turkish Studies
- Ukrainian Studies
- Western European Studies
- World Affairs
- Animal Studies
- Anthropology
- Archaeology
- Business, Management, and Marketing
- Media
- Critical Theory
- Disability Studies
- Drugs, Addiction and Recovery
- Education
- Economics
- Finance
- Geography
- Gender Studies
- Genocide Studies
- Higher Education
- Human Rights
- Journalism
- Language
- Law
- LGBTQ+ Studies
- National Security
- Philosophy
- Policing, Incarceration, and Reform
- Political Science
- Politics & Polemics
- Public Policy
- Sex, Sexuality, and Sex Work
- Sociology
- Sound Studies
- Sports
- Urban Studies
- Big Ideas
- Celebration Studies
- Co-Authored
- Cover Story
- Historical Materialism
- History Ex Silo
- Invested Investor
- Landscape Architecture
- Mormonism
- NBN Book of the Day
- NBN Seminar
- Postscript
- Practical History
- Preparing for Life After Grad School
- Psychology and Climate Change
- Interpretive Political and Social Science
Sep 2, 2022
The Tamiflu Trials
Profit and Public Health--How Do We Choose Which Drugs to Use?
Summary
Before Remdesivir and Hydroxycloroquin there was Tamiflu.
To prepare for Swine Flu and Bird Flu, governments spent billions stockpiling this drug called Tamiflu. You’d think governments used the best evidence-based advice, but the story of Tamiflu raises questions about how money shaped the process.
On this episode of Cited, Darts and Letters predecessor, we open up the black box of pharmaceutical and public health expertise. We tell the story of a drug, from its days as middling flu treatment through its meteoric rise to international blockbuster. How do experts decide what makes a good drug, and how do pharmaceutical companies make billions from pandemic panic?
—————————-SUPPORT THE SHOW—————————-
You can support the show for free by following or subscribing on Spotify, Apple Podcasts, or whichever app you use. This is the best way to help us out and it costs nothing so we’d really appreciate you clicking that button.
If you want to do a little more we would love it if you chip in. You can find us on patreon.com/dartsandletters. Patrons get content early, and occasionally there’s bonus material on there too.
——————-ABOUT THE SHOW——————
For a full list of credits, contact information, and more, visit our about page.
Your Host
Gordon Katic
Gordon Katic is an award-winning radio producer and journalist with a background in health, science, and climate reporting. He is director of Cited Media Productions, which produced Cited Podcast and CRACKDOWN. Now, Gordon hosts Darts and Letters. When he’s not making podcasts, he’s working on a PhD at the University of Toronto focussed on theorizing a critical theory of science communication. Previously, he earned a Masters in Journalism from the University of British Columbia.